Ocular Therapeutix OCUL Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ocular Therapeutix's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ocular Therapeutix's operating income?
- Ocular Therapeutix (OCUL) reported operating income of -$93.34M in Q1 2026.
- How has Ocular Therapeutix's operating income changed year-over-year?
- Ocular Therapeutix's operating income decreased by 46.0% year-over-year, from -$63.92M to -$93.34M.
- What is the long-term trend for Ocular Therapeutix's operating income?
- Over 4 years (2021 to 2025), Ocular Therapeutix's operating income has grown at a 36.4% compound annual growth rate (CAGR), from -$78.04M to -$270.02M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.